Skip to main content
OpenTrials
Completed

NCT Number: NCT05592041

Studying of Natural Constituents' Treatment of Plantar Warts

Moringa banana nigella and Banna coat extract were prepared and formulated in the form of bi gel for transdermal delivery of these plant extracts. The formulation was prepared and charterized for organoleptic charters, morphology, and penetration efficacy. The optimised formulation was assessed clinically on patients suffering from plantar warts. The clinical study was phase 1 and interventional randomised allocation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Plantar Wart

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Early Phase 1

Primary location

Soad A. Mohamad

Minya, 05673, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patient aged 18 years or more.
  • Clinical evaluation
  • Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm

Exclusion criteria

  • Patient suspected to be immunocompromised
  • Patient aged under 18 years
  • Patient refusing to sign the consent
  • Pregnant or lactating women

Treatment and study plan

Banaba Leaf Extract

Drug

a herbal extract in the form of Bigel

Other names: moringa banna nigella

Primary outcomes

  1. Complete clinical remission of the warts

    Time frame: 30 days

    Number of warts (counts)

  2. Clinical assessment of warts curement

    Time frame: 30 days

    Diameter of wart in cm

Secondary outcomes

  1. Pain asssesment

    Time frame: 30 days

    pain was assesed by VAS scoring (0) the least to (5) highest

Sponsors and collaborators

Lead sponsor

Deraya University

Other

Registry information

Official study title

In-vitro and Randomized Controlled Clinical Studying of Natural Constituents' Anti-HPV Potential for Treatment of Plantar Warts Supported With in Silico Studies

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Oct 24, 2022
Registry last updated
May 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.